In silico studies of phytoconstituents to identify potential inhibitors for erα protein of breast cancer

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/18240

Full metadata record

DC Field	Value	Language
dc.contributor.author	Murugesan, Sankaranarayanan	-
dc.date.accessioned	2025-03-10T09:20:44Z	-
dc.date.available	2025-03-10T09:20:44Z	-
dc.date.issued	2025-02	-
dc.identifier.uri	https://www.benthamdirect.com/content/journals/mc/10.2174/0115734064301748240821081206	-
dc.identifier.uri	http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/18240	-
dc.description.abstract	It is noteworthy that a wide array of plants and nutraceuticals are effectively utilized in the treatment of various cancers, demonstrating potent effects on different cancer targets with fewer side effects. Notably, estrogen alpha has been identified as a crucial factor in breast cancer cell proliferation. Agents that can antagonize its action hold promise as potential drug leads for the treatment of breast cancer.	en_US
dc.language.iso	en	en_US
dc.publisher	Bentham Science	en_US
dc.subject	Pharmacy	en_US
dc.subject	ADME(T)	en_US
dc.subject	Breast cancer	en_US
dc.subject	Drug development	en_US
dc.subject	MD analysis	en_US
dc.subject	Molecular docking	en_US
dc.subject	Nutraceuticals	en_US
dc.title	In silico studies of phytoconstituents to identify potential inhibitors for erα protein of breast cancer	en_US
dc.type	Article	en_US
Appears in Collections:	Department of Pharmacy

Files in This Item:

There are no files associated with this item.